All 252 IBB (ISHARES BIOTECHNOLOGY ETF) Holdings
There are 252 IBB holdings. Top 10 companies weight: 44.73%.
Total Market Cap: $1.60T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (252 stocks) | +19.98% | 23.69 | 17.29 | 0.53 | +25.34% | +9.82% | 0.81 | ||||||||||
51 | XENE | Xenon Pharmaceuticals Inc | 0.43% | $66.74 | $6.54B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +20.71% | $81 | +29.69% | 0.92 |
52 | TVTX | Travere Therapeutics Inc Ordinary Shares | 0.40% | $56.58 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +3.15% | $58 | +34.24% | 1.28 |
53 | SRRK | Scholar Rock Holding Corp | 0.40% | $50.88 | $6.44B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +16.57% | $59 | +9.01% | 0.67 |
54 | CRSP | Crispr Therapeutics Ag | 0.39% | $48.15 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +79.04% | $86 | -17.34% | 1.44 |
55 | ORKA | Oruka Therapeutics Inc | 0.37% | $94.32 | $4.35B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +53.38% | $145 | +32.89% | N/A |
56 | VCYT | Veracyte Inc | 0.36% | $59.53 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -5.01% | $57 | +9.24% | 1.36 |
57 | DFTX | N/A | 0.36% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
58 | LEGN | Legend Biotech Corp Adr | 0.35% | $23.54 | $4.26B | Biotechnology | Healthcare | -13.49% | N/A | 149.25 | N/A | N/A | N/A | 80 | +136.32% | $56 | -13.66% | 0.49 |
59 | n/a | Blackrock Cash Funds Treasury Sl Agency | 0.35% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
60 | TXG | N/A | 0.34% | $47.20 | $5.87B | Health Information Services | Healthcare | N/A | N/A | 714.29 | N/A | N/A | N/A | 60 | -15.57% | $40 | -23.98% | 2.05 |
61 | ACAD | Acadia Pharmaceuticals Inc | 0.33% | $25.43 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +28.39% | $33 | +2.73% | 0.90 |
62 | CGON | Cg Oncology Inc | 0.32% | $71.72 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +25.89% | $90 | 0.00% | 1.46 |
63 | DNLI | Denali Therapeutics Inc | 0.30% | $23.83 | $3.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +43.73% | $34 | -18.07% | 1.46 |
64 | CRNX | Crinetics Pharmaceuticals Inc | 0.29% | $83.90 | $8.84B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | 78 | -1.67% | $83 | +33.64% | 1.02 |
65 | TNGX | Tango Therapeutics Inc | 0.27% | $29.02 | $4.36B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +52.76% | $44 | +21.99% | 1.40 |
66 | ADPT | Adaptive Biotechnologies Corp | 0.27% | $22.58 | $3.66B | Diagnostics & Research | Healthcare | -22.53% | N/A | N/A | N/A | N/A | N/A | 78 | -2.57% | $22 | -9.75% | 1.71 |
67 | IBRX | Immunitybio Inc Ordinary Shares | 0.27% | $8.07 | $8.10B | Biotechnology | Healthcare | -9.78% | N/A | N/A | N/A | N/A | N/A | 83 | +61.09% | $13 | -6.28% | 1.57 |
68 | ERAS | Erasca Inc | 0.26% | $19.38 | $5.51B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +17.65% | $23 | -0.63% | 1.38 |
69 | BEAM | Beam Therapeutics Inc | 0.25% | $27.29 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +91.68% | $52 | -22.11% | 1.82 |
70 | EWTX | Edgewise Therapeutics Inc | 0.24% | $39.58 | $4.39B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +26.12% | $50 | +14.06% | 1.37 |
71 | IMVT | Immunovant Inc | 0.24% | $39.53 | $8.13B | Biotechnology | Healthcare | +18.52% | N/A | N/A | N/A | N/A | N/A | 70 | +19.38% | $47 | +31.25% | 1.21 |
72 | GPCR | Structure Therapeutics Inc Adr | 0.24% | $49.35 | $3.53B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +111.94% | $105 | 0.00% | 0.83 |
73 | RLAY | Relay Therapeutics Inc Ordinary Shares | 0.23% | $19.30 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +31.50% | $25 | -10.84% | 1.84 |
74 | RARE | Ultragenyx Pharmaceutical Inc | 0.23% | $28.62 | $3.12B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +83.54% | $53 | -19.29% | 0.97 |
75 | IDYA | Ideaya Biosciences Inc | 0.23% | $35.99 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +45.29% | $52 | +10.10% | 1.11 |
76 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.22% | $23.83 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +64.50% | $39 | +4.50% | 1.77 |
77 | NAMS | Newamsterdam Pharma Co Nv | 0.22% | $32.34 | $3.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +53.71% | $50 | 0.00% | 1.02 |
78 | ARQT | N/A | 0.22% | $28.26 | $3.47B | Biotechnology | Healthcare | -58.89% | N/A | 158.73 | N/A | N/A | N/A | N/A | N/A | N/A | +2.52% | N/A |
79 | ELVN | Enliven Therapeutics Inc | 0.21% | $54.33 | $3.24B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +21.48% | $66 | +19.34% | 1.17 |
80 | GRAL | Grail Inc | 0.21% | $72.71 | $3.06B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 61 | -3.56% | $70 | 0.00% | 2.23 |
81 | QURE | Uniqure Nv | 0.20% | $40.09 | $2.58B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 75 | +61.39% | $65 | +8.64% | 0.99 |
82 | RCUS | Arcus Biosciences Inc | 0.19% | $29.48 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +21.27% | $36 | -2.24% | 1.50 |
83 | VERA | Vera Therapeutics Inc Class A | 0.19% | $37.17 | $3.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +120.04% | $82 | +17.52% | 1.22 |
84 | TARS | N/A | 0.19% | $57.26 | $2.47B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +65.14% | $95 | +17.34% | 0.62 |
85 | NTLA | Intellia Therapeutics Inc | 0.18% | $11.47 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +128.16% | $26 | -40.03% | 1.78 |
86 | CAI | Caris Life Sciences Inc | 0.18% | $15.73 | $4.94B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 71 | +71.65% | $27 | 0.00% | 1.42 |
87 | VCEL | Vericel Corp | 0.18% | $46.14 | $2.38B | Biotechnology | Healthcare | +35.66% | 109.92 | 98.04 | 0.18 | N/A | N/A | 71 | +23.84% | $57 | -2.68% | 1.13 |
88 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.18% | $23.48 | $2.47B | Biotechnology | Healthcare | +10.31% | N/A | N/A | N/A | N/A | N/A | 81 | +38.42% | $33 | -5.21% | 1.36 |
89 | ALMS | Alumis Inc | 0.17% | $30.05 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +33.44% | $40 | 0.00% | 0.88 |
90 | KOD | Kodiak Sciences Inc | 0.17% | $42.42 | $2.64B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 78 | +47.74% | $63 | -12.93% | 1.69 |
91 | IRON | Disc Medicine Inc Ordinary Shares | 0.16% | $75.58 | $2.90B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +34.36% | $102 | +8.36% | 1.15 |
92 | AGIO | Agios Pharmaceuticals Inc | 0.16% | $37.36 | $2.37B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +14.08% | $43 | -6.09% | 1.01 |
93 | BCRX | Biocryst Pharmaceuticals Inc | 0.16% | $9.42 | $2.39B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 86.96 | N/A | N/A | N/A | N/A | N/A | N/A | -11.11% | N/A |
94 | SMMT | Summit Therapeutics Inc Ordinary Shares | 0.15% | $14.63 | $12B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +96.24% | $29 | +13.03% | 1.76 |
95 | BHVN | Biohaven Ltd | 0.15% | $15.50 | $2.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +46.77% | $23 | 0.00% | 1.46 |
96 | ADMA | Adma Biologics Inc | 0.15% | $8.59 | $2.02B | Biotechnology | Healthcare | N/A | 12.42 | 10.50 | N/A | N/A | N/A | 75 | +97.90% | $17 | +40.30% | 1.16 |
97 | AUPH | Aurinia Pharmaceuticals Inc | 0.14% | $15.64 | $2.11B | Biotechnology | Healthcare | N/A | 9.58 | 18.38 | 0.02 | N/A | N/A | 64 | +8.70% | $17 | +6.21% | 0.72 |
98 | ABCL | Abcellera Biologics Inc Ordinary Shares | 0.14% | $5.97 | $2.05B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +75.88% | $11 | -17.93% | 1.66 |
99 | ZYME | Zymeworks Inc Registered Shs | 0.14% | $24.05 | $1.80B | Biotechnology | Healthcare | N/A | N/A | 23.75 | N/A | N/A | N/A | 79 | +63.53% | $39 | -7.81% | 0.83 |
100 | SRPT | Sarepta Therapeutics Inc | 0.14% | $16.21 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.76 | 159.25 | N/A | N/A | 48 | +36.77% | $22 | -25.17% | 1.40 |
IBB (ISHARES BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
94.30%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%